Clinical Trial Update: Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

View source ↗

Summary

Clinical trial update announcing recruitment for the MiRDA-C study investigating minimal residual disease in colorectal cancer across multiple stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8 | Status: RECRUITING